3月30日,复星国际有限公司(00656.HK)公布2024年度业绩报告。在全球经济波动背景下,集团通过深化“瘦身健体,有进有退”战略,实现总收入人民币1,921.4亿元,产业运营利润达人民币49亿元,海外收入占比攀升至49.3%,展现战略转型成效。核心业务稳中提质四大核心子公司豫园股份、复星医药、复星葡萄牙保险及复星旅文合计贡献收入1,346.5亿元,占总收入70.1%。集团总债务比率稳定在...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.